Guided Therapeutics (GTHP) Debt to Equity (2011 - 2025)
Guided Therapeutics recorded quarterly Debt to Equity of -$0.01 in Q4 2025, up 47.22% quarter-over-quarter from -$0.02 in Q3 2025, and up 70.37% year-over-year from -$0.01 in Q4 2024.
Guided Therapeutics' Debt to Equity history runs 14 years deep, the most recent figure standing at -$0.01 for Q4 2025.
- In Q4 2025, Debt to Equity rose 70.37% year-over-year to -$0.01; the TTM figure through Dec 2025 stood at -$0.01 (up 70.37% YoY), while the FY2025 annual figure was -$0.01, up 70.37% from the prior year.
- Debt to Equity came in at -$0.01 for Q4 2025 at Guided Therapeutics, up from -$0.02 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.01 in Q1 2021 to a low of -$0.25 in Q2 2024.
- A 4-year average of -$0.07 and a median of -$0.02 in 2022 frame the typical range for Debt to Equity.
- Across the five-year window, Debt to Equity tumbled 3545.45% in 2021 and jumped 93.19% in 2025, its largest moves.
- Guided Therapeutics' Debt to Equity stood at -$0.02 in 2021, then sank by 71.7% to -$0.03 in 2022, then increased by 2.7% to -$0.03 in 2024, then surged by 70.37% to -$0.01 in 2025.
- According to Business Quant data, Debt to Equity over the past three periods registered -$0.01, -$0.02, and -$0.02 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.25 |
| Dec 31, 2022 | -0.03 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | -0.12 |
| Dec 31, 2021 | -0.02 |
| Sep 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.11 |
| Mar 31, 2021 | -0.01 |
| Dec 31, 2020 | -0.03 |
| Sep 30, 2020 | -0.04 |
| Jun 30, 2020 | 0.00 |
| Mar 31, 2020 | -0.05 |
| Dec 31, 2019 | -0.03 |
| Sep 30, 2019 | -0.06 |
| Jun 30, 2019 | -0.03 |
| Mar 31, 2019 | -0.02 |
| Dec 31, 2018 | -0.02 |
| Sep 30, 2018 | -0.04 |
| Dec 31, 2017 | -0.06 |
| Mar 31, 2017 | -0.07 |
| Dec 31, 2016 | -0.18 |
| Sep 30, 2016 | -0.09 |
| Dec 31, 2015 | -0.15 |
| Jun 30, 2015 | -0.38 |
| Mar 31, 2015 | -0.03 |
| Dec 31, 2014 | -0.04 |
| Sep 30, 2014 | -0.04 |
| Jun 30, 2014 | -0.07 |
| Mar 31, 2014 | -0.17 |
| Dec 31, 2013 | -1.98 |
| Sep 30, 2013 | 0.46 |
| Jun 30, 2013 | 0.15 |
| Mar 31, 2013 | 0.05 |
| Dec 31, 2012 | 0.00 |
| Sep 30, 2012 | 0.01 |
| Jun 30, 2012 | 0.04 |
| Mar 31, 2012 | 0.03 |
| Dec 31, 2011 | 0.02 |
| Jun 30, 2011 | 0.06 |